TLOG — Tetralogic Pharmaceuticals Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $24.92m
Annual balance sheet for Tetralogic Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2011 December 31st | 2012 December 31st | 2013 December 31st | R2014 December 31st | 2015 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 15.5 | 4.51 | 55.1 | 53.7 | 20.4 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 16 | 4.66 | 55.3 | 55.5 | 22 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.297 | 0.172 | 0.14 | 0.528 | 0.418 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 16.3 | 4.89 | 55.5 | 117 | 64 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 3.49 | 3.12 | 4.93 | 5.12 | 3.66 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 3.53 | 7.91 | 4.95 | 83.2 | 70 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 12.8 | -3.02 | 50.5 | 33.4 | -5.94 |
Total Liabilities & Shareholders' Equity | 16.3 | 4.89 | 55.5 | 117 | 64 |
Total Common Shares Outstanding |